Program Profile
-
Program Profile
A Transdisciplinary Program for Care of Veterans With Neurocognitive Disorders
Veterans face specific risk factors for neurocognitive disorders. Providing them with comprehensive care for dementia and related neurocognitive...
-
Program Profile
Transition to Tenecteplase From t-PA for Acute Ischemic Stroke at Walter Reed National Military Medical Center
Tissue plasminogen activator (t-PA) has been the standard IV thrombolytic drug used in acute ischemic stroke treatment since 1995. Tenecteplase...
Original Research
-
Original Research
Assessment of IV Edaravone Use in the Management of Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disorder that results in progressive...
Commentary
-
Commentary
Discontinuing Disease-Modifying Therapies in Nonactive Secondary Progressive MS:Review of the Evidence
Background: There are currently no disease-modifying therapies (DMTs) on the market approved for nonactive secondary...